GRAPE KING BIO LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 158 TWD | 0.00% |
|
+0.96% | +1.28% |
| 27/02 | Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 09/01 | Grape King Bio Hits Record-High Sales of NT$10.64 Billion in 2023 | MT |
Chart calendar Grape King Bio Ltd
2.QAtlG4PjTpNzJBtQQPQMQBnq3e29cbxL9ZFN4KgXGFI.FFMvQ86WK_83d3k5J7F9OlisiqDoC4p9hdcAsNtxUjwLOzdN5LkA3kFVaA~022b1ffbc9a43a7b9ee537bb52c9132d
Upcoming events on Grape King Bio Ltd
Past events on Grape King Bio Ltd
| 09/04/2024 | March 2024 Sales and Revenue Release |
| 08/03/2024 | February 2024 Sales and Revenue Release |
| 27/02/2024 12:02 pm | Q4 2023 Earnings Release |
| 15/02/2024 12:00 pm | January 2024 Sales and Revenue Release |
| 08/01/2024 12:00 pm | December 2023 Sales and Revenue Release |
| 09/11/2023 | Q3 2023 Earnings Release |
| 06/10/2023 | September 2023 Sales and Revenue Release |
| 06/09/2023 12:00 pm | August 2023 Sales and Revenue Release |
| 10/08/2023 12:02 pm | Q2 2023 Earnings Release |
| 09/08/2023 01:56 pm | July 2023 Sales and Revenue Release |
| 31/05/2023 06:30 am | Annual General Meeting |
| 12/04/2023 06:30 am | TWSE and Quantum International Corp CEO Conference |
| 11/04/2023 11:30 am | KGI Securities Conference |
| 23/02/2018 | FY 2017 Earnings Release |
Past dividends on Grape King Bio Ltd
| 20/06/2023 | Annual 6.9 TWD |
| 15/06/2022 | Annual 6.1 TWD |
| 02/08/2021 | Annual 6.4 TWD |
| 24/06/2020 | Annual 6.5 TWD |
| 24/06/2019 | Annual 6.5 TWD |
| 09/07/2018 | Annual 6.67601 TWD |
| 11/07/2017 | Annual 6.4 TWD |
| 18/07/2016 | Annual 5.595944 TWD |
| 27/07/2015 | Annual 5.3 TWD |
| 09/07/2014 | Annual 5 TWD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 9 239 9 199 0.44% | 9 168 9 073 1.05% | 9 798 9 783 0.16% | 10 391 10 391 -0% | 10 635 10 671 -0.33% | 11 529 |
|
EBITDA Million TWD | Released Forecast Spread | 2 654 2 666 -0.44% | 2 720 2 673 1.77% | 2 739 2 802 -2.23% | 3 001 3 037 -1.17% | 2 956 3 023 -2.21% | 3 159 |
|
EBIT Million TWD | Released Forecast Spread | 2 335 2 323 0.53% | 2 305 2 297 0.33% | 2 312 2 350 -1.63% | 2 552 2 589 -1.44% | 2 497 2 520 -0.92% | 2 721 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 2 440 2 418 0.92% | 2 378 2 376 0.09% | 2 415 2 460 -1.84% | 2 688 2 721 -1.2% | 2 661 2 688 -1.01% | 2 898 |
|
Net income Million TWD | Released Forecast Spread | 1 309 1 303 0.49% | 1 272 1 271 0.12% | 1 300 1 316 -1.21% | 1 457 1 473 -1.08% | 1 453 1 471 -1.26% | 1 599 |
|
EPS TWD | Released Forecast Spread | 9,63 9,58 0.47% | 9,29 9,26 0.31% | 8,76 8,87 -1.28% | 9,78 9,92 -1.41% | 9,74 9,90 -1.61% | 10,6 |
| Announcement Date | 24/02/20 | 26/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 2 919 2 895 0.82% | 2 053 2 159 -4.93% | 2 722 2 604 4.55% | 2 492 2 549 -2.23% | 3 124 3 114 0.33% | 2 220 2 290 -3.07% | 2 665 2 705 -1.49% | 2 551 2 594 -1.67% | 3 200 3 316 -3.49% | 2 384 | 2 882 | 2 813 | 3 554 |
|
EBITDA Million TWD | Released Forecast Spread | 876 | 780 612 27.6% | |||||||||||
|
EBIT Million TWD | Released Forecast Spread | 768 825 -6.95% | 422 472 -10.7% | 668 612 9.21% | 639 603 6.03% | 823 874 -5.89% | 478 470 1.75% | 562 636 -11.62% | 634 621 2.1% | 822 909 -9.54% | 501 | 643 | 684 | 944 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 802 848 -5.43% | 448 498 -10.07% | 702 632 10.98% | 672 587 14.6% | 866 897 -3.41% | 511 495 3.14% | 606 | 681 584 16.68% | 862 941 -8.37% | 530 | 675 | 717 | 976 |
|
Net income Million TWD | Released Forecast Spread | 440 452 -2.72% | 236 273 -13.76% | 385 361 6.64% | 365 320 14.13% | 472 485 -2.77% | 280 268 4.59% | 338 | 367 308 19.07% | 468 518 -9.59% | 285 | 374 | 393 | 547 |
|
EPS TWD | Released Forecast Spread | 2,95 3,08 -4.22% | 1,58 1,85 -14.44% | 2,59 2,14 21.31% | 2,45 2,16 13.6% | 3,16 3,27 -3.36% | 1,88 1,81 4.16% | 2,28 | 2,47 2,08 18.75% | 3,13 3,50 -10.57% | 1,92 | 2,52 | 2,65 | 3,69 |
| Announcement Date | 24/02/22 | 12/05/22 | 11/08/22 | 08/11/22 | 23/02/23 | 10/05/23 | 10/08/23 | 10/11/23 | 27/02/24 | - | - | - | - |
More events
Past sector events for Grape King Bio Ltd
| Today | BELLRING BRANDS, INC.: Q2 2024 Earnings Release |
| 02/05/2024 02:05 am | HERBALIFE LTD.: Q1 2024 Earnings Release |
| 01/05/2024 01:35 am | USANA HEALTH SCIENCES, INC.: Q1 2024 Earnings Release |
| 30/04/2024 | XIAMEN KINGDOMWAY GROUP COMPANY: Q1 2024 Earnings Release |
| 29/04/2024 | ZHEJIANG NHU COMPANY LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | BYHEALTH CO., LTD: Q1 2024 Earnings Release |
| 23/04/2024 | CSPC INNOVATION PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release |
| 23/04/2024 | ZHEJIANG NHU COMPANY LTD.: Q4 2023 Earnings Release |
| 22/04/2024 | SIRIO PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 22/04/2024 | SIRIO PHARMA CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1707 Stock
- Calendar Grape King Bio Ltd